GlassScriptPhysician profile
Jeffery Michael Shea
NPI 1972658425
$7,183.56
in general payments reported to CMS, 2019-2025
42 companies · $1,466 in 2025
The $1,466 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,023 · 2020: $556 · 2021: $1,390 · 2022: $961 · 2023: $958 · 2024: $830 · 2025: $1,466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,237 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,237.06 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,984.78 | 2019-2025 | Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $927.15 | 2019-2025 | Ofev |
| Astrazeneca Pharmaceuticals LP | $616.25 | 2019-2025 | Airsupra, Breztri, Tezspire |
| Mylan Specialty L.P. | $557.23 | 2019-2024 | Yupelri |
| United Therapeutics Corporation | $386.32 | 2021-2025 | Tyvaso, Tyvaso |
| Jazz Pharmaceuticals INC. | $352.34 | 2019-2025 | |
| Insmed, INC. | $280.25 | 2019-2025 | Arikayce, Brinsupri |
| Axsome Therapeutics, INC. | $246.98 | 2023-2025 | Sunosi |
| Genzyme Corporation | $228.23 | 2024-2025 | |
| Grifols USA, LLC | $177.17 | 2019-2025 | Prolastin-C Liquid |
| Actelion Pharmaceuticals US, INC. | $173.13 | 2019-2024 | Uptravi, Opsumit |
| Electromed, INC. | $131.18 | 2022-2025 | Smartvest |
| Baxter Healthcare | $115.69 | 2023-2025 | Hillrom - Vest System Model 105 Home Care |
| Advanced Respiratory, INC | $100.87 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $85.44 | 2021 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $78.75 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $72.88 | 2020-2025 | Glassia |
| Inspire Medical Systems, INC. | $71.47 | 2023-2025 | Inspire |
| Gilead Sciences, INC. | $48.61 | 2021 | |
| Genentech USA, INC. | $44.56 | 2019-2021 | |
| Inogen, INC. | $41.07 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Shionogi INC | $39.59 | 2022-2025 | Fetroja |
| Sunovion Pharmaceuticals INC. | $38.21 | 2019 | |
| Merck Sharp & Dohme LLC | $37.34 | 2021-2024 | Zerbaxa, Recarbrio |
| Verona Pharma, INC. | $35.65 | 2025 | Ohtuvayre |
| Lilly USA, LLC | $32.68 | 2025 | Zepbound |
| Regeneron Healthcare Solutions, INC. | $28.18 | 2024 | Dupixent |
| Veran Medical Technologies, INC. | $25.18 | 2019 | |
| Zoll Respicardia, INC. | $23.54 | 2023 | Remede System |
| 3b Medical, INC. | $22.81 | 2025 | Luna |
| Eisai INC. | $21.78 | 2020 | |
| Pfizer INC. | $21.49 | 2021 | |
| Philips North America LLC | $19.79 | 2024 | (Ak6) Vest Therapy |
| Itamar Medical INC | $19.08 | 2023 | Watchpatone |
| Cmp Pharma, INC. | $18.94 | 2023 | Tadliq |
| Olympus America INC. | $18.77 | 2025 | Single-Use Flexible Video Bronchoscope |
| Ethicon INC. | $18.25 | 2025 | Monarch Platform |
| Mallinckrodt Hospital Products INC. | $16.31 | 2023 | Acthar |
| Liquidia Technologies, INC. | $13.79 | 2025 | Yutrepia |
| Shire North American Group INC | $11.83 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffery Shea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.